Global Acute Vulvovaginal Candidiasis Treatment Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Acute vulvovaginal candidiasis is a fungal/yeast infection, which is caused by some species of Candida, especially Candida albicans. Increasing cases of vulvovaginal candidiasis can be attributed to ageing, overuse of antibiotics, diabetes, etc. Doctors are involved in prescribing medicines on the basis of their efficiency in controlling acute vulvovaginal candidiasis among the patients.
LPI (LP Information)' newest research report, the “Acute Vulvovaginal Candidiasis Treatment Industry Forecast” looks at past sales and reviews total world Acute Vulvovaginal Candidiasis Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Acute Vulvovaginal Candidiasis Treatment sales for 2023 through 2029. With Acute Vulvovaginal Candidiasis Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Acute Vulvovaginal Candidiasis Treatment industry.
This Insight Report provides a comprehensive analysis of the global Acute Vulvovaginal Candidiasis Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Acute Vulvovaginal Candidiasis Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Acute Vulvovaginal Candidiasis Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Acute Vulvovaginal Candidiasis Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Acute Vulvovaginal Candidiasis Treatment.
The global Acute Vulvovaginal Candidiasis Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Acute Vulvovaginal Candidiasis Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Acute Vulvovaginal Candidiasis Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Acute Vulvovaginal Candidiasis Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Acute Vulvovaginal Candidiasis Treatment players cover Mycovia Pharmaceuticals, Inc, Scynexis, Inc, Basilea Pharmaceutica Ltd, Astellas Pharma Inc, Grupo Ferrer Internacional, S.A, Pacgen Life Science Corporation, NovaDigm Therapeutics, Inc, Cidara Therapeutics, Inc and Amplyx Pharmaceuticals Inc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Acute Vulvovaginal Candidiasis Treatment market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Acute vulvovaginal candidiasis is a fungal/yeast infection, which is caused by some species of Candida, especially Candida albicans. Increasing cases of vulvovaginal candidiasis can be attributed to ageing, overuse of antibiotics, diabetes, etc. Doctors are involved in prescribing medicines on the basis of their efficiency in controlling acute vulvovaginal candidiasis among the patients.
LPI (LP Information)' newest research report, the “Acute Vulvovaginal Candidiasis Treatment Industry Forecast” looks at past sales and reviews total world Acute Vulvovaginal Candidiasis Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Acute Vulvovaginal Candidiasis Treatment sales for 2023 through 2029. With Acute Vulvovaginal Candidiasis Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Acute Vulvovaginal Candidiasis Treatment industry.
This Insight Report provides a comprehensive analysis of the global Acute Vulvovaginal Candidiasis Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Acute Vulvovaginal Candidiasis Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Acute Vulvovaginal Candidiasis Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Acute Vulvovaginal Candidiasis Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Acute Vulvovaginal Candidiasis Treatment.
The global Acute Vulvovaginal Candidiasis Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Acute Vulvovaginal Candidiasis Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Acute Vulvovaginal Candidiasis Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Acute Vulvovaginal Candidiasis Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Acute Vulvovaginal Candidiasis Treatment players cover Mycovia Pharmaceuticals, Inc, Scynexis, Inc, Basilea Pharmaceutica Ltd, Astellas Pharma Inc, Grupo Ferrer Internacional, S.A, Pacgen Life Science Corporation, NovaDigm Therapeutics, Inc, Cidara Therapeutics, Inc and Amplyx Pharmaceuticals Inc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Acute Vulvovaginal Candidiasis Treatment market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Clotrimazole
- Nystatin
- Fluconazole
- Ketoconazole
- Terbinafine
- Terconazole
- Others
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Mycovia Pharmaceuticals, Inc
- Scynexis, Inc
- Basilea Pharmaceutica Ltd
- Astellas Pharma Inc
- Grupo Ferrer Internacional, S.A
- Pacgen Life Science Corporation
- NovaDigm Therapeutics, Inc
- Cidara Therapeutics, Inc
- Amplyx Pharmaceuticals Inc
- Pfizer, Inc.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Acute Vulvovaginal Candidiasis Treatment Market Size 2018-2029
2.1.2 Acute Vulvovaginal Candidiasis Treatment Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Acute Vulvovaginal Candidiasis Treatment Segment by Type
2.2.1 Clotrimazole
2.2.2 Nystatin
2.2.3 Fluconazole
2.2.4 Ketoconazole
2.2.5 Terbinafine
2.2.6 Terconazole
2.2.7 Others
2.3 Acute Vulvovaginal Candidiasis Treatment Market Size by Type
2.3.1 Acute Vulvovaginal Candidiasis Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Type (2018-2023)
2.4 Acute Vulvovaginal Candidiasis Treatment Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Acute Vulvovaginal Candidiasis Treatment Market Size by Application
2.5.1 Acute Vulvovaginal Candidiasis Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Application (2018-2023)
3 ACUTE VULVOVAGINAL CANDIDIASIS TREATMENT MARKET SIZE BY PLAYER
3.1 Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Players
3.1.1 Global Acute Vulvovaginal Candidiasis Treatment Revenue by Players (2018-2023)
3.1.2 Global Acute Vulvovaginal Candidiasis Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Acute Vulvovaginal Candidiasis Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ACUTE VULVOVAGINAL CANDIDIASIS TREATMENT BY REGIONS
4.1 Acute Vulvovaginal Candidiasis Treatment Market Size by Regions (2018-2023)
4.2 Americas Acute Vulvovaginal Candidiasis Treatment Market Size Growth (2018-2023)
4.3 APAC Acute Vulvovaginal Candidiasis Treatment Market Size Growth (2018-2023)
4.4 Europe Acute Vulvovaginal Candidiasis Treatment Market Size Growth (2018-2023)
4.5 Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Acute Vulvovaginal Candidiasis Treatment Market Size by Country (2018-2023)
5.2 Americas Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2018-2023)
5.3 Americas Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Acute Vulvovaginal Candidiasis Treatment Market Size by Region (2018-2023)
6.2 APAC Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2018-2023)
6.3 APAC Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Acute Vulvovaginal Candidiasis Treatment by Country (2018-2023)
7.2 Europe Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2018-2023)
7.3 Europe Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Acute Vulvovaginal Candidiasis Treatment by Region (2018-2023)
8.2 Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2018-2023)
8.3 Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ACUTE VULVOVAGINAL CANDIDIASIS TREATMENT MARKET FORECAST
10.1 Global Acute Vulvovaginal Candidiasis Treatment Forecast by Regions (2024-2029)
10.1.1 Global Acute Vulvovaginal Candidiasis Treatment Forecast by Regions (2024-2029)
10.1.2 Americas Acute Vulvovaginal Candidiasis Treatment Forecast
10.1.3 APAC Acute Vulvovaginal Candidiasis Treatment Forecast
10.1.4 Europe Acute Vulvovaginal Candidiasis Treatment Forecast
10.1.5 Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Forecast
10.2 Americas Acute Vulvovaginal Candidiasis Treatment Forecast by Country (2024-2029)
10.2.1 United States Acute Vulvovaginal Candidiasis Treatment Market Forecast
10.2.2 Canada Acute Vulvovaginal Candidiasis Treatment Market Forecast
10.2.3 Mexico Acute Vulvovaginal Candidiasis Treatment Market Forecast
10.2.4 Brazil Acute Vulvovaginal Candidiasis Treatment Market Forecast
10.3 APAC Acute Vulvovaginal Candidiasis Treatment Forecast by Region (2024-2029)
10.3.1 China Acute Vulvovaginal Candidiasis Treatment Market Forecast
10.3.2 Japan Acute Vulvovaginal Candidiasis Treatment Market Forecast
10.3.3 Korea Acute Vulvovaginal Candidiasis Treatment Market Forecast
10.3.4 Southeast Asia Acute Vulvovaginal Candidiasis Treatment Market Forecast
10.3.5 India Acute Vulvovaginal Candidiasis Treatment Market Forecast
10.3.6 Australia Acute Vulvovaginal Candidiasis Treatment Market Forecast
10.4 Europe Acute Vulvovaginal Candidiasis Treatment Forecast by Country (2024-2029)
10.4.1 Germany Acute Vulvovaginal Candidiasis Treatment Market Forecast
10.4.2 France Acute Vulvovaginal Candidiasis Treatment Market Forecast
10.4.3 UK Acute Vulvovaginal Candidiasis Treatment Market Forecast
10.4.4 Italy Acute Vulvovaginal Candidiasis Treatment Market Forecast
10.4.5 Russia Acute Vulvovaginal Candidiasis Treatment Market Forecast
10.5 Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Forecast by Region (2024-2029)
10.5.1 Egypt Acute Vulvovaginal Candidiasis Treatment Market Forecast
10.5.2 South Africa Acute Vulvovaginal Candidiasis Treatment Market Forecast
10.5.3 Israel Acute Vulvovaginal Candidiasis Treatment Market Forecast
10.5.4 Turkey Acute Vulvovaginal Candidiasis Treatment Market Forecast
10.5.5 GCC Countries Acute Vulvovaginal Candidiasis Treatment Market Forecast
10.6 Global Acute Vulvovaginal Candidiasis Treatment Forecast by Type (2024-2029)
10.7 Global Acute Vulvovaginal Candidiasis Treatment Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Mycovia Pharmaceuticals, Inc
11.1.1 Mycovia Pharmaceuticals, Inc Company Information
11.1.2 Mycovia Pharmaceuticals, Inc Acute Vulvovaginal Candidiasis Treatment Product Offered
11.1.3 Mycovia Pharmaceuticals, Inc Acute Vulvovaginal Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Mycovia Pharmaceuticals, Inc Main Business Overview
11.1.5 Mycovia Pharmaceuticals, Inc Latest Developments
11.2 Scynexis, Inc
11.2.1 Scynexis, Inc Company Information
11.2.2 Scynexis, Inc Acute Vulvovaginal Candidiasis Treatment Product Offered
11.2.3 Scynexis, Inc Acute Vulvovaginal Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Scynexis, Inc Main Business Overview
11.2.5 Scynexis, Inc Latest Developments
11.3 Basilea Pharmaceutica Ltd
11.3.1 Basilea Pharmaceutica Ltd Company Information
11.3.2 Basilea Pharmaceutica Ltd Acute Vulvovaginal Candidiasis Treatment Product Offered
11.3.3 Basilea Pharmaceutica Ltd Acute Vulvovaginal Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Basilea Pharmaceutica Ltd Main Business Overview
11.3.5 Basilea Pharmaceutica Ltd Latest Developments
11.4 Astellas Pharma Inc
11.4.1 Astellas Pharma Inc Company Information
11.4.2 Astellas Pharma Inc Acute Vulvovaginal Candidiasis Treatment Product Offered
11.4.3 Astellas Pharma Inc Acute Vulvovaginal Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Astellas Pharma Inc Main Business Overview
11.4.5 Astellas Pharma Inc Latest Developments
11.5 Grupo Ferrer Internacional, S.A
11.5.1 Grupo Ferrer Internacional, S.A Company Information
11.5.2 Grupo Ferrer Internacional, S.A Acute Vulvovaginal Candidiasis Treatment Product Offered
11.5.3 Grupo Ferrer Internacional, S.A Acute Vulvovaginal Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Grupo Ferrer Internacional, S.A Main Business Overview
11.5.5 Grupo Ferrer Internacional, S.A Latest Developments
11.6 Pacgen Life Science Corporation
11.6.1 Pacgen Life Science Corporation Company Information
11.6.2 Pacgen Life Science Corporation Acute Vulvovaginal Candidiasis Treatment Product Offered
11.6.3 Pacgen Life Science Corporation Acute Vulvovaginal Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Pacgen Life Science Corporation Main Business Overview
11.6.5 Pacgen Life Science Corporation Latest Developments
11.7 NovaDigm Therapeutics, Inc
11.7.1 NovaDigm Therapeutics, Inc Company Information
11.7.2 NovaDigm Therapeutics, Inc Acute Vulvovaginal Candidiasis Treatment Product Offered
11.7.3 NovaDigm Therapeutics, Inc Acute Vulvovaginal Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 NovaDigm Therapeutics, Inc Main Business Overview
11.7.5 NovaDigm Therapeutics, Inc Latest Developments
11.8 Cidara Therapeutics, Inc
11.8.1 Cidara Therapeutics, Inc Company Information
11.8.2 Cidara Therapeutics, Inc Acute Vulvovaginal Candidiasis Treatment Product Offered
11.8.3 Cidara Therapeutics, Inc Acute Vulvovaginal Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Cidara Therapeutics, Inc Main Business Overview
11.8.5 Cidara Therapeutics, Inc Latest Developments
11.9 Amplyx Pharmaceuticals Inc
11.9.1 Amplyx Pharmaceuticals Inc Company Information
11.9.2 Amplyx Pharmaceuticals Inc Acute Vulvovaginal Candidiasis Treatment Product Offered
11.9.3 Amplyx Pharmaceuticals Inc Acute Vulvovaginal Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Amplyx Pharmaceuticals Inc Main Business Overview
11.9.5 Amplyx Pharmaceuticals Inc Latest Developments
11.10 Pfizer, Inc.
11.10.1 Pfizer, Inc. Company Information
11.10.2 Pfizer, Inc. Acute Vulvovaginal Candidiasis Treatment Product Offered
11.10.3 Pfizer, Inc. Acute Vulvovaginal Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Pfizer, Inc. Main Business Overview
11.10.5 Pfizer, Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Acute Vulvovaginal Candidiasis Treatment Market Size 2018-2029
2.1.2 Acute Vulvovaginal Candidiasis Treatment Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Acute Vulvovaginal Candidiasis Treatment Segment by Type
2.2.1 Clotrimazole
2.2.2 Nystatin
2.2.3 Fluconazole
2.2.4 Ketoconazole
2.2.5 Terbinafine
2.2.6 Terconazole
2.2.7 Others
2.3 Acute Vulvovaginal Candidiasis Treatment Market Size by Type
2.3.1 Acute Vulvovaginal Candidiasis Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Type (2018-2023)
2.4 Acute Vulvovaginal Candidiasis Treatment Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Acute Vulvovaginal Candidiasis Treatment Market Size by Application
2.5.1 Acute Vulvovaginal Candidiasis Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Application (2018-2023)
3 ACUTE VULVOVAGINAL CANDIDIASIS TREATMENT MARKET SIZE BY PLAYER
3.1 Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Players
3.1.1 Global Acute Vulvovaginal Candidiasis Treatment Revenue by Players (2018-2023)
3.1.2 Global Acute Vulvovaginal Candidiasis Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Acute Vulvovaginal Candidiasis Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ACUTE VULVOVAGINAL CANDIDIASIS TREATMENT BY REGIONS
4.1 Acute Vulvovaginal Candidiasis Treatment Market Size by Regions (2018-2023)
4.2 Americas Acute Vulvovaginal Candidiasis Treatment Market Size Growth (2018-2023)
4.3 APAC Acute Vulvovaginal Candidiasis Treatment Market Size Growth (2018-2023)
4.4 Europe Acute Vulvovaginal Candidiasis Treatment Market Size Growth (2018-2023)
4.5 Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Acute Vulvovaginal Candidiasis Treatment Market Size by Country (2018-2023)
5.2 Americas Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2018-2023)
5.3 Americas Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Acute Vulvovaginal Candidiasis Treatment Market Size by Region (2018-2023)
6.2 APAC Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2018-2023)
6.3 APAC Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Acute Vulvovaginal Candidiasis Treatment by Country (2018-2023)
7.2 Europe Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2018-2023)
7.3 Europe Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Acute Vulvovaginal Candidiasis Treatment by Region (2018-2023)
8.2 Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2018-2023)
8.3 Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ACUTE VULVOVAGINAL CANDIDIASIS TREATMENT MARKET FORECAST
10.1 Global Acute Vulvovaginal Candidiasis Treatment Forecast by Regions (2024-2029)
10.1.1 Global Acute Vulvovaginal Candidiasis Treatment Forecast by Regions (2024-2029)
10.1.2 Americas Acute Vulvovaginal Candidiasis Treatment Forecast
10.1.3 APAC Acute Vulvovaginal Candidiasis Treatment Forecast
10.1.4 Europe Acute Vulvovaginal Candidiasis Treatment Forecast
10.1.5 Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Forecast
10.2 Americas Acute Vulvovaginal Candidiasis Treatment Forecast by Country (2024-2029)
10.2.1 United States Acute Vulvovaginal Candidiasis Treatment Market Forecast
10.2.2 Canada Acute Vulvovaginal Candidiasis Treatment Market Forecast
10.2.3 Mexico Acute Vulvovaginal Candidiasis Treatment Market Forecast
10.2.4 Brazil Acute Vulvovaginal Candidiasis Treatment Market Forecast
10.3 APAC Acute Vulvovaginal Candidiasis Treatment Forecast by Region (2024-2029)
10.3.1 China Acute Vulvovaginal Candidiasis Treatment Market Forecast
10.3.2 Japan Acute Vulvovaginal Candidiasis Treatment Market Forecast
10.3.3 Korea Acute Vulvovaginal Candidiasis Treatment Market Forecast
10.3.4 Southeast Asia Acute Vulvovaginal Candidiasis Treatment Market Forecast
10.3.5 India Acute Vulvovaginal Candidiasis Treatment Market Forecast
10.3.6 Australia Acute Vulvovaginal Candidiasis Treatment Market Forecast
10.4 Europe Acute Vulvovaginal Candidiasis Treatment Forecast by Country (2024-2029)
10.4.1 Germany Acute Vulvovaginal Candidiasis Treatment Market Forecast
10.4.2 France Acute Vulvovaginal Candidiasis Treatment Market Forecast
10.4.3 UK Acute Vulvovaginal Candidiasis Treatment Market Forecast
10.4.4 Italy Acute Vulvovaginal Candidiasis Treatment Market Forecast
10.4.5 Russia Acute Vulvovaginal Candidiasis Treatment Market Forecast
10.5 Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Forecast by Region (2024-2029)
10.5.1 Egypt Acute Vulvovaginal Candidiasis Treatment Market Forecast
10.5.2 South Africa Acute Vulvovaginal Candidiasis Treatment Market Forecast
10.5.3 Israel Acute Vulvovaginal Candidiasis Treatment Market Forecast
10.5.4 Turkey Acute Vulvovaginal Candidiasis Treatment Market Forecast
10.5.5 GCC Countries Acute Vulvovaginal Candidiasis Treatment Market Forecast
10.6 Global Acute Vulvovaginal Candidiasis Treatment Forecast by Type (2024-2029)
10.7 Global Acute Vulvovaginal Candidiasis Treatment Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Mycovia Pharmaceuticals, Inc
11.1.1 Mycovia Pharmaceuticals, Inc Company Information
11.1.2 Mycovia Pharmaceuticals, Inc Acute Vulvovaginal Candidiasis Treatment Product Offered
11.1.3 Mycovia Pharmaceuticals, Inc Acute Vulvovaginal Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Mycovia Pharmaceuticals, Inc Main Business Overview
11.1.5 Mycovia Pharmaceuticals, Inc Latest Developments
11.2 Scynexis, Inc
11.2.1 Scynexis, Inc Company Information
11.2.2 Scynexis, Inc Acute Vulvovaginal Candidiasis Treatment Product Offered
11.2.3 Scynexis, Inc Acute Vulvovaginal Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Scynexis, Inc Main Business Overview
11.2.5 Scynexis, Inc Latest Developments
11.3 Basilea Pharmaceutica Ltd
11.3.1 Basilea Pharmaceutica Ltd Company Information
11.3.2 Basilea Pharmaceutica Ltd Acute Vulvovaginal Candidiasis Treatment Product Offered
11.3.3 Basilea Pharmaceutica Ltd Acute Vulvovaginal Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Basilea Pharmaceutica Ltd Main Business Overview
11.3.5 Basilea Pharmaceutica Ltd Latest Developments
11.4 Astellas Pharma Inc
11.4.1 Astellas Pharma Inc Company Information
11.4.2 Astellas Pharma Inc Acute Vulvovaginal Candidiasis Treatment Product Offered
11.4.3 Astellas Pharma Inc Acute Vulvovaginal Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Astellas Pharma Inc Main Business Overview
11.4.5 Astellas Pharma Inc Latest Developments
11.5 Grupo Ferrer Internacional, S.A
11.5.1 Grupo Ferrer Internacional, S.A Company Information
11.5.2 Grupo Ferrer Internacional, S.A Acute Vulvovaginal Candidiasis Treatment Product Offered
11.5.3 Grupo Ferrer Internacional, S.A Acute Vulvovaginal Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Grupo Ferrer Internacional, S.A Main Business Overview
11.5.5 Grupo Ferrer Internacional, S.A Latest Developments
11.6 Pacgen Life Science Corporation
11.6.1 Pacgen Life Science Corporation Company Information
11.6.2 Pacgen Life Science Corporation Acute Vulvovaginal Candidiasis Treatment Product Offered
11.6.3 Pacgen Life Science Corporation Acute Vulvovaginal Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Pacgen Life Science Corporation Main Business Overview
11.6.5 Pacgen Life Science Corporation Latest Developments
11.7 NovaDigm Therapeutics, Inc
11.7.1 NovaDigm Therapeutics, Inc Company Information
11.7.2 NovaDigm Therapeutics, Inc Acute Vulvovaginal Candidiasis Treatment Product Offered
11.7.3 NovaDigm Therapeutics, Inc Acute Vulvovaginal Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 NovaDigm Therapeutics, Inc Main Business Overview
11.7.5 NovaDigm Therapeutics, Inc Latest Developments
11.8 Cidara Therapeutics, Inc
11.8.1 Cidara Therapeutics, Inc Company Information
11.8.2 Cidara Therapeutics, Inc Acute Vulvovaginal Candidiasis Treatment Product Offered
11.8.3 Cidara Therapeutics, Inc Acute Vulvovaginal Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Cidara Therapeutics, Inc Main Business Overview
11.8.5 Cidara Therapeutics, Inc Latest Developments
11.9 Amplyx Pharmaceuticals Inc
11.9.1 Amplyx Pharmaceuticals Inc Company Information
11.9.2 Amplyx Pharmaceuticals Inc Acute Vulvovaginal Candidiasis Treatment Product Offered
11.9.3 Amplyx Pharmaceuticals Inc Acute Vulvovaginal Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Amplyx Pharmaceuticals Inc Main Business Overview
11.9.5 Amplyx Pharmaceuticals Inc Latest Developments
11.10 Pfizer, Inc.
11.10.1 Pfizer, Inc. Company Information
11.10.2 Pfizer, Inc. Acute Vulvovaginal Candidiasis Treatment Product Offered
11.10.3 Pfizer, Inc. Acute Vulvovaginal Candidiasis Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Pfizer, Inc. Main Business Overview
11.10.5 Pfizer, Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Acute Vulvovaginal Candidiasis Treatment Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Clotrimazole
Table 3. Major Players of Nystatin
Table 4. Major Players of Fluconazole
Table 5. Major Players of Ketoconazole
Table 6. Major Players of Terbinafine
Table 7. Major Players of Terconazole
Table 8. Major Players of Others
Table 9. Acute Vulvovaginal Candidiasis Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 11. Global Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Type (2018-2023)
Table 12. Acute Vulvovaginal Candidiasis Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 13. Global Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 14. Global Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Application (2018-2023)
Table 15. Global Acute Vulvovaginal Candidiasis Treatment Revenue by Players (2018-2023) & ($ Millions)
Table 16. Global Acute Vulvovaginal Candidiasis Treatment Revenue Market Share by Player (2018-2023)
Table 17. Acute Vulvovaginal Candidiasis Treatment Key Players Head office and Products Offered
Table 18. Acute Vulvovaginal Candidiasis Treatment Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Acute Vulvovaginal Candidiasis Treatment Market Size by Regions 2018-2023 & ($ Millions)
Table 22. Global Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Regions (2018-2023)
Table 23. Global Acute Vulvovaginal Candidiasis Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 24. Global Acute Vulvovaginal Candidiasis Treatment Revenue Market Share by Country/Region (2018-2023)
Table 25. Americas Acute Vulvovaginal Candidiasis Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 26. Americas Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Country (2018-2023)
Table 27. Americas Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 28. Americas Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Type (2018-2023)
Table 29. Americas Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 30. Americas Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Application (2018-2023)
Table 31. APAC Acute Vulvovaginal Candidiasis Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 32. APAC Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Region (2018-2023)
Table 33. APAC Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 34. APAC Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Type (2018-2023)
Table 35. APAC Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 36. APAC Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Application (2018-2023)
Table 37. Europe Acute Vulvovaginal Candidiasis Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 38. Europe Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Country (2018-2023)
Table 39. Europe Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 40. Europe Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Type (2018-2023)
Table 41. Europe Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 42. Europe Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Application (2018-2023)
Table 43. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Region (2018-2023)
Table 45. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 46. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Type (2018-2023)
Table 47. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 48. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Application (2018-2023)
Table 49. Key Market Drivers & Growth Opportunities of Acute Vulvovaginal Candidiasis Treatment
Table 50. Key Market Challenges & Risks of Acute Vulvovaginal Candidiasis Treatment
Table 51. Key Industry Trends of Acute Vulvovaginal Candidiasis Treatment
Table 52. Global Acute Vulvovaginal Candidiasis Treatment Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 53. Global Acute Vulvovaginal Candidiasis Treatment Market Size Market Share Forecast by Regions (2024-2029)
Table 54. Global Acute Vulvovaginal Candidiasis Treatment Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 55. Global Acute Vulvovaginal Candidiasis Treatment Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 56. Mycovia Pharmaceuticals, Inc Details, Company Type, Acute Vulvovaginal Candidiasis Treatment Area Served and Its Competitors
Table 57. Mycovia Pharmaceuticals, Inc Acute Vulvovaginal Candidiasis Treatment Product Offered
Table 58. Mycovia Pharmaceuticals, Inc Acute Vulvovaginal Candidiasis Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 59. Mycovia Pharmaceuticals, Inc Main Business
Table 60. Mycovia Pharmaceuticals, Inc Latest Developments
Table 61. Scynexis, Inc Details, Company Type, Acute Vulvovaginal Candidiasis Treatment Area Served and Its Competitors
Table 62. Scynexis, Inc Acute Vulvovaginal Candidiasis Treatment Product Offered
Table 63. Scynexis, Inc Main Business
Table 64. Scynexis, Inc Acute Vulvovaginal Candidiasis Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Scynexis, Inc Latest Developments
Table 66. Basilea Pharmaceutica Ltd Details, Company Type, Acute Vulvovaginal Candidiasis Treatment Area Served and Its Competitors
Table 67. Basilea Pharmaceutica Ltd Acute Vulvovaginal Candidiasis Treatment Product Offered
Table 68. Basilea Pharmaceutica Ltd Main Business
Table 69. Basilea Pharmaceutica Ltd Acute Vulvovaginal Candidiasis Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Basilea Pharmaceutica Ltd Latest Developments
Table 71. Astellas Pharma Inc Details, Company Type, Acute Vulvovaginal Candidiasis Treatment Area Served and Its Competitors
Table 72. Astellas Pharma Inc Acute Vulvovaginal Candidiasis Treatment Product Offered
Table 73. Astellas Pharma Inc Main Business
Table 74. Astellas Pharma Inc Acute Vulvovaginal Candidiasis Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Astellas Pharma Inc Latest Developments
Table 76. Grupo Ferrer Internacional, S.A Details, Company Type, Acute Vulvovaginal Candidiasis Treatment Area Served and Its Competitors
Table 77. Grupo Ferrer Internacional, S.A Acute Vulvovaginal Candidiasis Treatment Product Offered
Table 78. Grupo Ferrer Internacional, S.A Main Business
Table 79. Grupo Ferrer Internacional, S.A Acute Vulvovaginal Candidiasis Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Grupo Ferrer Internacional, S.A Latest Developments
Table 81. Pacgen Life Science Corporation Details, Company Type, Acute Vulvovaginal Candidiasis Treatment Area Served and Its Competitors
Table 82. Pacgen Life Science Corporation Acute Vulvovaginal Candidiasis Treatment Product Offered
Table 83. Pacgen Life Science Corporation Main Business
Table 84. Pacgen Life Science Corporation Acute Vulvovaginal Candidiasis Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Pacgen Life Science Corporation Latest Developments
Table 86. NovaDigm Therapeutics, Inc Details, Company Type, Acute Vulvovaginal Candidiasis Treatment Area Served and Its Competitors
Table 87. NovaDigm Therapeutics, Inc Acute Vulvovaginal Candidiasis Treatment Product Offered
Table 88. NovaDigm Therapeutics, Inc Main Business
Table 89. NovaDigm Therapeutics, Inc Acute Vulvovaginal Candidiasis Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. NovaDigm Therapeutics, Inc Latest Developments
Table 91. Cidara Therapeutics, Inc Details, Company Type, Acute Vulvovaginal Candidiasis Treatment Area Served and Its Competitors
Table 92. Cidara Therapeutics, Inc Acute Vulvovaginal Candidiasis Treatment Product Offered
Table 93. Cidara Therapeutics, Inc Main Business
Table 94. Cidara Therapeutics, Inc Acute Vulvovaginal Candidiasis Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Cidara Therapeutics, Inc Latest Developments
Table 96. Amplyx Pharmaceuticals Inc Details, Company Type, Acute Vulvovaginal Candidiasis Treatment Area Served and Its Competitors
Table 97. Amplyx Pharmaceuticals Inc Acute Vulvovaginal Candidiasis Treatment Product Offered
Table 98. Amplyx Pharmaceuticals Inc Main Business
Table 99. Amplyx Pharmaceuticals Inc Acute Vulvovaginal Candidiasis Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Amplyx Pharmaceuticals Inc Latest Developments
Table 101. Pfizer, Inc. Details, Company Type, Acute Vulvovaginal Candidiasis Treatment Area Served and Its Competitors
Table 102. Pfizer, Inc. Acute Vulvovaginal Candidiasis Treatment Product Offered
Table 103. Pfizer, Inc. Main Business
Table 104. Pfizer, Inc. Acute Vulvovaginal Candidiasis Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Pfizer, Inc. Latest Developments
Table 1. Acute Vulvovaginal Candidiasis Treatment Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Clotrimazole
Table 3. Major Players of Nystatin
Table 4. Major Players of Fluconazole
Table 5. Major Players of Ketoconazole
Table 6. Major Players of Terbinafine
Table 7. Major Players of Terconazole
Table 8. Major Players of Others
Table 9. Acute Vulvovaginal Candidiasis Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 11. Global Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Type (2018-2023)
Table 12. Acute Vulvovaginal Candidiasis Treatment Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 13. Global Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 14. Global Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Application (2018-2023)
Table 15. Global Acute Vulvovaginal Candidiasis Treatment Revenue by Players (2018-2023) & ($ Millions)
Table 16. Global Acute Vulvovaginal Candidiasis Treatment Revenue Market Share by Player (2018-2023)
Table 17. Acute Vulvovaginal Candidiasis Treatment Key Players Head office and Products Offered
Table 18. Acute Vulvovaginal Candidiasis Treatment Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Acute Vulvovaginal Candidiasis Treatment Market Size by Regions 2018-2023 & ($ Millions)
Table 22. Global Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Regions (2018-2023)
Table 23. Global Acute Vulvovaginal Candidiasis Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 24. Global Acute Vulvovaginal Candidiasis Treatment Revenue Market Share by Country/Region (2018-2023)
Table 25. Americas Acute Vulvovaginal Candidiasis Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 26. Americas Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Country (2018-2023)
Table 27. Americas Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 28. Americas Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Type (2018-2023)
Table 29. Americas Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 30. Americas Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Application (2018-2023)
Table 31. APAC Acute Vulvovaginal Candidiasis Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 32. APAC Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Region (2018-2023)
Table 33. APAC Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 34. APAC Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Type (2018-2023)
Table 35. APAC Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 36. APAC Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Application (2018-2023)
Table 37. Europe Acute Vulvovaginal Candidiasis Treatment Market Size by Country (2018-2023) & ($ Millions)
Table 38. Europe Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Country (2018-2023)
Table 39. Europe Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 40. Europe Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Type (2018-2023)
Table 41. Europe Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 42. Europe Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Application (2018-2023)
Table 43. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size by Region (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Region (2018-2023)
Table 45. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size by Type (2018-2023) & ($ Millions)
Table 46. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Type (2018-2023)
Table 47. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size by Application (2018-2023) & ($ Millions)
Table 48. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Application (2018-2023)
Table 49. Key Market Drivers & Growth Opportunities of Acute Vulvovaginal Candidiasis Treatment
Table 50. Key Market Challenges & Risks of Acute Vulvovaginal Candidiasis Treatment
Table 51. Key Industry Trends of Acute Vulvovaginal Candidiasis Treatment
Table 52. Global Acute Vulvovaginal Candidiasis Treatment Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 53. Global Acute Vulvovaginal Candidiasis Treatment Market Size Market Share Forecast by Regions (2024-2029)
Table 54. Global Acute Vulvovaginal Candidiasis Treatment Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 55. Global Acute Vulvovaginal Candidiasis Treatment Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 56. Mycovia Pharmaceuticals, Inc Details, Company Type, Acute Vulvovaginal Candidiasis Treatment Area Served and Its Competitors
Table 57. Mycovia Pharmaceuticals, Inc Acute Vulvovaginal Candidiasis Treatment Product Offered
Table 58. Mycovia Pharmaceuticals, Inc Acute Vulvovaginal Candidiasis Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 59. Mycovia Pharmaceuticals, Inc Main Business
Table 60. Mycovia Pharmaceuticals, Inc Latest Developments
Table 61. Scynexis, Inc Details, Company Type, Acute Vulvovaginal Candidiasis Treatment Area Served and Its Competitors
Table 62. Scynexis, Inc Acute Vulvovaginal Candidiasis Treatment Product Offered
Table 63. Scynexis, Inc Main Business
Table 64. Scynexis, Inc Acute Vulvovaginal Candidiasis Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Scynexis, Inc Latest Developments
Table 66. Basilea Pharmaceutica Ltd Details, Company Type, Acute Vulvovaginal Candidiasis Treatment Area Served and Its Competitors
Table 67. Basilea Pharmaceutica Ltd Acute Vulvovaginal Candidiasis Treatment Product Offered
Table 68. Basilea Pharmaceutica Ltd Main Business
Table 69. Basilea Pharmaceutica Ltd Acute Vulvovaginal Candidiasis Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Basilea Pharmaceutica Ltd Latest Developments
Table 71. Astellas Pharma Inc Details, Company Type, Acute Vulvovaginal Candidiasis Treatment Area Served and Its Competitors
Table 72. Astellas Pharma Inc Acute Vulvovaginal Candidiasis Treatment Product Offered
Table 73. Astellas Pharma Inc Main Business
Table 74. Astellas Pharma Inc Acute Vulvovaginal Candidiasis Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Astellas Pharma Inc Latest Developments
Table 76. Grupo Ferrer Internacional, S.A Details, Company Type, Acute Vulvovaginal Candidiasis Treatment Area Served and Its Competitors
Table 77. Grupo Ferrer Internacional, S.A Acute Vulvovaginal Candidiasis Treatment Product Offered
Table 78. Grupo Ferrer Internacional, S.A Main Business
Table 79. Grupo Ferrer Internacional, S.A Acute Vulvovaginal Candidiasis Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Grupo Ferrer Internacional, S.A Latest Developments
Table 81. Pacgen Life Science Corporation Details, Company Type, Acute Vulvovaginal Candidiasis Treatment Area Served and Its Competitors
Table 82. Pacgen Life Science Corporation Acute Vulvovaginal Candidiasis Treatment Product Offered
Table 83. Pacgen Life Science Corporation Main Business
Table 84. Pacgen Life Science Corporation Acute Vulvovaginal Candidiasis Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Pacgen Life Science Corporation Latest Developments
Table 86. NovaDigm Therapeutics, Inc Details, Company Type, Acute Vulvovaginal Candidiasis Treatment Area Served and Its Competitors
Table 87. NovaDigm Therapeutics, Inc Acute Vulvovaginal Candidiasis Treatment Product Offered
Table 88. NovaDigm Therapeutics, Inc Main Business
Table 89. NovaDigm Therapeutics, Inc Acute Vulvovaginal Candidiasis Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. NovaDigm Therapeutics, Inc Latest Developments
Table 91. Cidara Therapeutics, Inc Details, Company Type, Acute Vulvovaginal Candidiasis Treatment Area Served and Its Competitors
Table 92. Cidara Therapeutics, Inc Acute Vulvovaginal Candidiasis Treatment Product Offered
Table 93. Cidara Therapeutics, Inc Main Business
Table 94. Cidara Therapeutics, Inc Acute Vulvovaginal Candidiasis Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Cidara Therapeutics, Inc Latest Developments
Table 96. Amplyx Pharmaceuticals Inc Details, Company Type, Acute Vulvovaginal Candidiasis Treatment Area Served and Its Competitors
Table 97. Amplyx Pharmaceuticals Inc Acute Vulvovaginal Candidiasis Treatment Product Offered
Table 98. Amplyx Pharmaceuticals Inc Main Business
Table 99. Amplyx Pharmaceuticals Inc Acute Vulvovaginal Candidiasis Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Amplyx Pharmaceuticals Inc Latest Developments
Table 101. Pfizer, Inc. Details, Company Type, Acute Vulvovaginal Candidiasis Treatment Area Served and Its Competitors
Table 102. Pfizer, Inc. Acute Vulvovaginal Candidiasis Treatment Product Offered
Table 103. Pfizer, Inc. Main Business
Table 104. Pfizer, Inc. Acute Vulvovaginal Candidiasis Treatment Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Pfizer, Inc. Latest Developments
LIST OF FIGURES
Figure 1. Acute Vulvovaginal Candidiasis Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Acute Vulvovaginal Candidiasis Treatment Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Acute Vulvovaginal Candidiasis Treatment Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Acute Vulvovaginal Candidiasis Treatment Sales Market Share by Country/Region (2022)
Figure 8. Acute Vulvovaginal Candidiasis Treatment Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Type in 2022
Figure 10. Acute Vulvovaginal Candidiasis Treatment in Hospital Pharmacies
Figure 11. Global Acute Vulvovaginal Candidiasis Treatment Market: Hospital Pharmacies (2018-2023) & ($ Millions)
Figure 12. Acute Vulvovaginal Candidiasis Treatment in Retail Pharmacies
Figure 13. Global Acute Vulvovaginal Candidiasis Treatment Market: Retail Pharmacies (2018-2023) & ($ Millions)
Figure 14. Acute Vulvovaginal Candidiasis Treatment in Online Pharmacies
Figure 15. Global Acute Vulvovaginal Candidiasis Treatment Market: Online Pharmacies (2018-2023) & ($ Millions)
Figure 16. Global Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Application in 2022
Figure 17. Global Acute Vulvovaginal Candidiasis Treatment Revenue Market Share by Player in 2022
Figure 18. Global Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Acute Vulvovaginal Candidiasis Treatment Market Size 2018-2023 ($ Millions)
Figure 20. APAC Acute Vulvovaginal Candidiasis Treatment Market Size 2018-2023 ($ Millions)
Figure 21. Europe Acute Vulvovaginal Candidiasis Treatment Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size 2018-2023 ($ Millions)
Figure 23. Americas Acute Vulvovaginal Candidiasis Treatment Value Market Share by Country in 2022
Figure 24. United States Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Region in 2022
Figure 29. APAC Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Type in 2022
Figure 30. APAC Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Application in 2022
Figure 31. China Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Country in 2022
Figure 38. Europe Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Type (2018-2023)
Figure 39. Europe Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Application (2018-2023)
Figure 40. Germany Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 54. APAC Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 55. Europe Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 57. United States Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 58. Canada Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 61. China Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 62. Japan Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 63. Korea Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 65. India Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 66. Australia Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 67. Germany Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 68. France Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 69. UK Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 70. Italy Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 71. Russia Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 72. Spain Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 75. Israel Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 78. Global Acute Vulvovaginal Candidiasis Treatment Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Acute Vulvovaginal Candidiasis Treatment Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Acute Vulvovaginal Candidiasis Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Acute Vulvovaginal Candidiasis Treatment Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Acute Vulvovaginal Candidiasis Treatment Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Acute Vulvovaginal Candidiasis Treatment Sales Market Share by Country/Region (2022)
Figure 8. Acute Vulvovaginal Candidiasis Treatment Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Type in 2022
Figure 10. Acute Vulvovaginal Candidiasis Treatment in Hospital Pharmacies
Figure 11. Global Acute Vulvovaginal Candidiasis Treatment Market: Hospital Pharmacies (2018-2023) & ($ Millions)
Figure 12. Acute Vulvovaginal Candidiasis Treatment in Retail Pharmacies
Figure 13. Global Acute Vulvovaginal Candidiasis Treatment Market: Retail Pharmacies (2018-2023) & ($ Millions)
Figure 14. Acute Vulvovaginal Candidiasis Treatment in Online Pharmacies
Figure 15. Global Acute Vulvovaginal Candidiasis Treatment Market: Online Pharmacies (2018-2023) & ($ Millions)
Figure 16. Global Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Application in 2022
Figure 17. Global Acute Vulvovaginal Candidiasis Treatment Revenue Market Share by Player in 2022
Figure 18. Global Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Acute Vulvovaginal Candidiasis Treatment Market Size 2018-2023 ($ Millions)
Figure 20. APAC Acute Vulvovaginal Candidiasis Treatment Market Size 2018-2023 ($ Millions)
Figure 21. Europe Acute Vulvovaginal Candidiasis Treatment Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size 2018-2023 ($ Millions)
Figure 23. Americas Acute Vulvovaginal Candidiasis Treatment Value Market Share by Country in 2022
Figure 24. United States Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Region in 2022
Figure 29. APAC Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Type in 2022
Figure 30. APAC Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Application in 2022
Figure 31. China Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Country in 2022
Figure 38. Europe Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Type (2018-2023)
Figure 39. Europe Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Application (2018-2023)
Figure 40. Germany Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Acute Vulvovaginal Candidiasis Treatment Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 54. APAC Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 55. Europe Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 57. United States Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 58. Canada Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 61. China Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 62. Japan Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 63. Korea Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 65. India Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 66. Australia Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 67. Germany Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 68. France Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 69. UK Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 70. Italy Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 71. Russia Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 72. Spain Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 75. Israel Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Acute Vulvovaginal Candidiasis Treatment Market Size 2024-2029 ($ Millions)
Figure 78. Global Acute Vulvovaginal Candidiasis Treatment Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Acute Vulvovaginal Candidiasis Treatment Market Size Market Share Forecast by Application (2024-2029)
